me 3221 has been researched along with Blood Pressure, High in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, M; Hachisu, M; Hui, C; Konno, F; Nagura, J; Yamamoto, M; Yasuda, S | 2 |
Hachisu, M; Hui, C; Konno, F; Nagura, J; Yamamoto, M; Yasuda, S | 1 |
3 other study(ies) available for me 3221 and Blood Pressure, High
Article | Year |
---|---|
ME3221, a surmountable angiotensin AT1-receptor antagonist, prevents hypertensive complications in aged stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Brain; Cerebrovascular Disorders; Enalapril; Heart; Hypertension; Imidazoles; Kidney; Losartan; Male; Myocardium; Rats; Rats, Inbred SHR; Tetrazoles | 1996 |
Protective effects of ME3221 on hypertensive complications and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Body Weight; Cerebral Hemorrhage; Dose-Response Relationship, Drug; Enalapril; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1996 |
Effect of chronic treatment with ME3221 on blood pressure and mortality in aged stroke-prone spontaneously hypertensive rats.
Topics: Aging; Angiotensin I; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Cerebral Hemorrhage; Cerebrovascular Disorders; Hypertension; Longevity; Male; Organ Size; Rats; Rats, Inbred SHR; Survival Rate; Tetrazoles | 1995 |